Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 14, 2018 - Issue
Submit an article Journal homepage
117
Views
7
CrossRef citations to date
0
Altmetric
Review

Functioning outcomes with adjunctive treatments for major depressive disorder: a systematic review of randomized placebo-controlled studies

Emmanuelle Weiller1 H. Lundbeck A/S, Valby, Copenhagen, DenmarkCorrespondence[email protected]
,
Catherine Weiss2 Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA
,
Christopher P Watling3 Cambridge Medical Communication Ltd, Cambridge, UK
,
Christopher Edge3 Cambridge Medical Communication Ltd, Cambridge, UK
,
Mary Hobart2 Otsuka Pharmaceutical Development & Commercialization Inc., Princeton, NJ, USA
,
Hans Eriksson1 H. Lundbeck A/S, Valby, Copenhagen, Denmark
&
Maurizio Fava4 Division of Clinical Research of the MGH Research Institute;5 Department of Psychiatry;6 Clinical Trials Network & Institute (CTNI), Massachusetts General Hospital, Boston, MA, USA
 show all
Pages 103-115 | Published online: 29 Dec 2017

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mary Hobart, Aleksandar Skuban, Peter Zhang, Mette Krog Josiassen, Nanco Hefting, Carole Augustine, Claudette Brewer, Raymond Sanchez & Robert D. McQuade. (2018) Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study. Current Medical Research and Opinion 34:4, pages 633-642.
Read now

Articles from other publishers (6)

Emma Morton, Venkat Bhat, Peter Giacobbe, Wendy Lou, Erin E. Michalak, Trisha Chakrabarty, Benicio N. Frey, Roumen V. Milev, Daniel J. Müller, Sagar V. Parikh, Susan Rotzinger, Sidney H. Kennedy & Raymond W. Lam. (2021) Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report. Pharmacopsychiatry 54:05, pages 225-231.
Crossref
Michael J. Grossman & Christopher R. Bowie. (2021) Money talks: The influence of extrinsic motivators on social cognition in early episode psychosis. Schizophrenia Research 233, pages 52-59.
Crossref
Emma Morton, Venkat Bhat, Peter Giacobbe, Wendy Lou, Erin E. Michalak, Shane McInerney, Trisha Chakrabarty, Benicio N. Frey, Roumen V. Milev, Daniel J. Müller, Sagar V. Parikh, Susan Rotzinger, Sidney H. Kennedy & Raymond W. Lam. (2021) Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report. CNS Drugs 35:4, pages 439-450.
Crossref
Bing Cao, Lu Xu, Yan Chen, Dongfang Wang, Yena Lee, Joshua D. Rosenblat, Xiao Gao, Siyan Zhan, Feng Sun & Roger S. McIntyre. (2021) Comparative efficacy of pharmacological treatments on measures of self-rated functional outcomes using the Sheehan Disability Scale in patients with major depressive disorder: a systematic review and network meta-analysis. CNS Spectrums, pages 1-9.
Crossref
Taro Kishi, Kenji Sakuma, Ikuo Nomura, Yuki Matsuda, Kazuo Mishima & Nakao Iwata. (2019) Brexpiprazole as Adjunctive Treatment for Major Depressive Disorder Following Treatment Failure With at Least One Antidepressant in the Current Episode: a Systematic Review and Meta-Analysis. International Journal of Neuropsychopharmacology 22:11, pages 698-709.
Crossref
Mary HobartPeter ZhangCatherine WeissStine Rasmussen MeehanHans Eriksson. (2018) Adjunctive Brexpiprazole and Functioning in Major Depressive Disorder: A Pooled Analysis of Six Randomized Studies Using the Sheehan Disability Scale. International Journal of Neuropsychopharmacology.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.